Skip to content
DataLookout
Menu

NCT07762443

A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata

StatusRecruiting
PhasePhase 1
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened
    • Eligibility criteria expanded, about 7 words
    • Start date changed from estimate of Sep 30, 2026 to Sep 22, 2026
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Area Under the Curve From Time Zero to Last Quantifiable Concentration(AUC)
Timeframe: Day1,Day28
Peak Plasma Concentration (Cmax)
Timeframe: Day1,Day28

Arms and interventions

VC005 Tablets Low Dose groupsExperimental
VC005 Tablets High Dose groupsExperimental

Drugs: VC005 tablets

Sites

1 site in 1 country

  • The Peking University People's HospitalBeijing, Beijing Municipality, China